Exosomics

Develops a simple, effective blood test for the early detection of multiple types of cancer. By exploiting exosome biology, this liquid biopsy technology enables tumours to be identified at a very early stage, even in asymptomatic patients. The aim is to make this detection available worldwide, using standard laboratory techniques and at an affordable cost.